primeimages/E+ via Getty Images
In this article I will provide my take on the most recent earnings call for Henry Schein, Inc (NASDAQ:HSIC) the health care distribution company that I last wrote about on March 11, 2025. In that article
Henry Schein Post Earnings Review
Summary
- Henry Schein's Q1 earnings were solid, with full-year EPS guidance of $4.80-$4.94 and analysts expecting $5.27 in 2026.
- New business units and revamped sales incentives aim to reignite revenue growth after stagnation since 2022; management is optimistic about their impact.
- Ongoing share buybacks (32% reduction in shares since 2011) continue to support EPS and provide downside support for the stock.
- HSIC's price action is bullish, trading above its 30-week EMA; I maintain price targets of $82 and $92 as momentum improves.
As an individual investor nearing retirement I am trying to build my financial assets in order to have a fulfilling retirement. I am interested in trading both long and short; or at least using inverse ETFs, to take advantage of market declines. Having long term and short term trading strategies, proper execution of my trading plan, and absolute investing results are my goals. I see my articles as a way to keep me focused on developing winning trades. I also expect to learn much from the feedback that is provided in the comments section.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in HSIC over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.